吉贝尔股价跌1.01%，广发基金旗下1只基金位居十大流通股东，持有95.9万股浮亏损失28.77万元

Group 1 - The core point of the news is that Jibeier Pharmaceutical Co., Ltd. experienced a stock decline of 1.01%, with a current share price of 29.27 yuan and a total market capitalization of 5.837 billion yuan [1] - Jibeier's main business involves drug research, production, and sales, with the revenue composition being: Likujun tablets 72.72%, Niquinlor tablets 14.20%, Yupingfeng capsules 4.88%, others 4.53%, and Acetylsalicylic acid enteric-coated tablets 3.67% [1] Group 2 - Among Jibeier's top ten circulating shareholders, one fund from GF Fund Management, the GF Healthcare Stock A (004851), entered the top ten in the third quarter, holding 959,000 shares, which is 0.48% of the circulating shares [2] - The GF Healthcare Stock A fund has a total size of 5.185 billion yuan, with a year-to-date return of 10.16%, ranking 3520 out of 4195 in its category [2] - The fund manager, Wu Xingwu, has a tenure of 10 years and 325 days, with the fund's total asset size at 10.641 billion yuan and a best return of 85.08% during his tenure [3]